ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $9,000 | -92.5% | 6,217 | -91.1% | 0.00% | – |
| Q1 2021 | $120,000 | +51.9% | 70,013 | +10.1% | 0.00% | – |
| Q4 2020 | $79,000 | +17.9% | 63,607 | +36.2% | 0.00% | – |
| Q3 2020 | $67,000 | +45.7% | 46,688 | +24.9% | 0.00% | – |
| Q2 2020 | $46,000 | +53.3% | 37,384 | +49.8% | 0.00% | – |
| Q1 2020 | $30,000 | -45.5% | 24,951 | -6.0% | 0.00% | – |
| Q4 2019 | $55,000 | +25.0% | 26,539 | +31.0% | 0.00% | – |
| Q3 2019 | $44,000 | -68.8% | 20,259 | -64.1% | 0.00% | – |
| Q2 2019 | $141,000 | +14000.0% | 56,432 | +9563.0% | 0.00% | – |
| Q1 2019 | $1,000 | -99.2% | 584 | -98.4% | 0.00% | – |
| Q2 2018 | $122,000 | – | 36,152 | +40520.2% | 0.00% | – |
| Q1 2018 | $0 | – | 89 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 89 | -99.9% | 0.00% | – |
| Q3 2017 | $580,000 | -7.9% | 126,264 | -57.0% | 0.00% | – |
| Q2 2017 | $630,000 | -18.3% | 293,770 | +19.6% | 0.00% | -100.0% |
| Q1 2017 | $771,000 | +49.7% | 245,674 | +23.8% | 0.00% | – |
| Q4 2016 | $515,000 | -23.9% | 198,517 | +13.8% | 0.00% | – |
| Q3 2016 | $677,000 | -33.2% | 174,454 | -53.8% | 0.00% | -100.0% |
| Q2 2016 | $1,013,000 | -34.8% | 377,691 | -25.1% | 0.00% | 0.0% |
| Q1 2016 | $1,553,000 | -22.7% | 504,584 | -3.3% | 0.00% | 0.0% |
| Q4 2015 | $2,008,000 | +97.6% | 522,056 | +56.5% | 0.00% | 0.0% |
| Q3 2015 | $1,016,000 | +21.2% | 333,560 | +68.7% | 0.00% | 0.0% |
| Q2 2015 | $838,000 | -29.3% | 197,766 | -35.8% | 0.00% | 0.0% |
| Q1 2015 | $1,186,000 | +175.8% | 307,932 | +381.5% | 0.00% | – |
| Q4 2014 | $430,000 | +35.2% | 63,951 | +9.9% | 0.00% | – |
| Q3 2014 | $318,000 | +200.0% | 58,208 | +458.4% | 0.00% | – |
| Q2 2014 | $106,000 | -56.9% | 10,424 | -49.4% | 0.00% | – |
| Q1 2014 | $246,000 | -64.8% | 20,606 | -66.7% | 0.00% | -100.0% |
| Q4 2013 | $699,000 | -10.2% | 61,962 | -14.5% | 0.00% | 0.0% |
| Q3 2013 | $778,000 | – | 72,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |